Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus

BackgroundElevated triglycerides or triglyceride-rich lipoproteins are an additional cause of cardiovascular (CV) disease. Given that patients with systemic lupus erythematosus (SLE) have a high prevalence of premature CV disease and show an altered lipid profile, our objective was to study whether...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Juan Carlos Quevedo-Abeledo, Candelaria Martín-González, Carmen Ferrer-Moure, Laura de Armas-Rillo, Maria Vanesa Hernandez-Hernandez, Miguel Á. González-Gay, Iván Ferraz-Amaro
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2022-05-01
Colección:Frontiers in Immunology
Materias:
systemic lupus erythematosus
dyslipidemia
lipoprotein lipase
angiopoietin-like protein 4
apolipoprotein C3
Acceso en línea:https://www.frontiersin.org/articles/10.3389/fimmu.2022.827355/full
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares